Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Remote patient monitoring platform
Digital health platform for remote patient monitoring, virtual wards and decentralised clinical trials, backed by AstraZeneca and Bayer.
The read
Huma runs a cloud platform for remote patient monitoring, hospital-at-home and virtual wards, and decentralised clinical trials, used by pharma companies, hospitals and governments. Backed by AstraZeneca and Bayer's venture arms, it has grown partly by acquisition, most notably absorbing the NHS triage platform eConsult Health in October 2024.
Its diabetes management programme, GDm-Health, is live in 64-plus NHS trusts, and the company has positioned itself as an end-to-end digital health infrastructure provider spanning triage through to remote monitoring.
The Bridgehead view
Huma's acquisition of eConsult turns two separate categories, patient triage and remote monitoring, into one platform story; the integration challenge is proving those parts work as a single system rather than a portfolio of separately-branded products.
Work with us
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
Related platforms
GP-founded online triage and consultation platform used across thousands of NHS practices, now operating as part of Huma Therapeutics following its 2024 acquisition.
ReadDigital pathway platform letting NHS clinicians capture patient photos, video and forms remotely, used across wound care, tissue viability and 40-plus specialties.
ReadASX-listed 24/7 virtual GP and allied-health service partnering with insurers and employers, best known for powering AXA's Doctor at Hand.
ReadThe firm that knows medtech
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.